Blood cancer sufferers to be offered pioneering new immunity drugs as 'standard care' on NHS following trial success with patients who did not respond to other drugs
Related Articles
-
New Bill Seeks to End Drug Shortages
The Senate Finance Committee wants to create a new program to incentivize better practices. Critics say there’s an easier way: end kickbacks between suppliers and bulk purchasers.
-
7 days with Rabbit R1: 7 things it does terribly — and 7 things it does well
I've spent seven days so far with the Rabbit R1. Here are seven things it does terribly — and seven things it does well.
-
The cancer drugs that could improve survival rates if given to patients in the morning
A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs - at the start of the day instead of after lunchtime.